 |
Management |
|
|
|
|
 | Ernst Hafen
|
|
|
|
| Ernst Hafen obtained his PhD from the Biocenter at the University of Basel in 1983. After a position as a postdoctoral fellow at the University of California in Berkeley from 1984 to 1986, he joined the Zoological Institute of the University of Zurich as an assistant professor in 1987. After promotion to associate (1994) and full professor (1997) he served as the director of the Zoological Institute from 2004 to 2005. In 2005 he accepted a professorship at the Institute of Molecular Systems Biology at the Department of Biology at ETH Zurich. From 2005 to 2007 he served as president of ETH Zürich. Ernst Hafen has made key contributions to the field of developmental biology and cell biology. These include the development of an in situhybridization method and its application to the localization of transcripts from homeotic genes and segmentation genes, the characterization of genes and the corresponding signaling pathways involved in photoreceptor cell fate specification and in the control of cell and body size. He received several prizes and has served on the Editorial Boards of various journals and scientific committees including the review board of the Swiss National Science Foundation. He is a co-founder of the Genetics Company, a privately held biotech company in Zurich-Schlieren. | |
|
 | Harald Eistetter
|
|
|
|
| Dr. Harald Eistetter holds a PhD from the University of Tuebingen, Germany, and has more than two decades of leadership experience in the pharmaceutical and biotech industry. He started his professional career with Byk Gulden/Altana Pharma and subsequently held senior management positions within Glaxo, Knoll/BASF Pharma, The Genetics Company Inc. and Indivumed GmbH. His scientific interests are in the fileds of oncology, neuroscience and enabling technologies. | |
|
 | Mathis Brauchbar
|
|
|
|
Mathis Brauchbar did his studies at the University of Basel where he obtained a master in molecular biology from the Biocenter. During his studies he started to work as a science writer for various newspapers and magazines in Switzerland, Germany, France and Austria. 1989 he founded Locher, Brauchbar & Partners AG (today: Locher, Schmill, Van Wezemael & Partner AG), an office for communication, consulting and planning in issues like health care, social security, energy and ecology. 1993 to 1996 he headed the project "Biotechnology and Foods" as part of the technology assessment program of the Swiss Science Council. In 2001 Mathis Brauchbar co-founded the firm advocacy, communication and consulting for public affairs and issues in health care and corporate social responsibility. And in 2002 he started to build up and manage the Zurich branch of advocacy. Major clients of advocacy are Fortune 500 companies and Top 100 Universities according to the Shanghai University Ranking.
| |
|
